Evidence-based data

Global Diabetic Foot Ulcer Statistics

Diabetic foot ulcers (DFU) are among the most serious — and most preventable — complications of diabetes. These figures, drawn from the IDF Diabetes Atlas, WHO reports, and peer-reviewed research, quantify the scale of the problem and the impact of specialised care.

Data last reviewed: 2024 · Sources listed at page bottom

The global diabetes burden

537M Adults living with diabetes worldwide (2021) IDF Diabetes Atlas, 10th ed.
1/2 Adults with diabetes are undiagnosed globally IDF Diabetes Atlas, 10th ed.
643M Projected adults with diabetes by 2030 IDF Diabetes Atlas, 10th ed.
6.7M Deaths attributed to diabetes in 2021 IDF Diabetes Atlas, 10th ed.

Diabetic foot ulcer prevalence & risk

15–25% Lifetime risk of developing a DFU for people with diabetes Armstrong et al., NEJM 2017
2% Annual incidence — new DFU cases per year among diabetics Armstrong et al., NEJM 2017
85% Of non-traumatic lower limb amputations are preceded by a DFU Pecoraro et al., Diabetes Care 1990; confirmed by multiple meta-analyses
40% DFU recurrence within 1 year of healing; 65% within 5 years Armstrong et al., NEJM 2017
DFU mortality is comparable to many cancers. Studies report 5-year all-cause mortality following a DFU episode in the range of 30–50%, higher than that of breast cancer or prostate cancer. Early intervention dramatically improves survival. Moulik et al., Diabetes Care 2003; Walsh et al., BMJ Open Diabetes Research & Care 2019

DFU prevalence by world region

A 2017 systematic review and meta-analysis of 67 studies across 33 countries found significant regional variation in DFU prevalence — shaped by differences in healthcare access, screening programs, and diabetes management.

13.0% North America — the highest reported DFU prevalence among diabetic patients Zhang P et al., Annals of Medicine 2017
7.2% Africa Zhang P et al., Annals of Medicine 2017
5.5% Asia Zhang P et al., Annals of Medicine 2017
5.1% Europe Zhang P et al., Annals of Medicine 2017
3.0% Oceania — the lowest reported prevalence Zhang P et al., Annals of Medicine 2017
~33 million people worldwide are living with a diabetic foot ulcer. At a global prevalence of 6.3% among the world's 537 million adults with diabetes, the absolute number of people affected by DFU at any given time is comparable to the entire population of Malaysia or Peru. Zhang P et al., Annals of Medicine 2017; IDF Diabetes Atlas, 10th ed.

China's diabetic foot burden

China carries the world's largest absolute diabetes burden. This scale has driven the development of highly specialised multidisciplinary DFU centres — which now achieve outcomes that compare favourably with the world's leading institutions.

140M+ Adults with diabetes in China — the world's largest diabetic population IDF Diabetes Atlas, 10th ed. (2021)
4.1% DFU prevalence among Chinese diabetic patients Wang et al., Diabetes Care 2017
~2.8M Estimated new DFU cases per year in China (140M × 2% annual incidence) Derived from IDF Atlas + Armstrong et al.

The amputation crisis

Every 30 seconds, a lower limb is lost to diabetes somewhere in the world. Boulton AJM et al., The Lancet 2005; IDF
1M+ Lower limb amputations performed annually due to diabetes worldwide Boulton AJM et al., The Lancet 2005
94% Of studies show multidisciplinary teams (MDT) reduce major amputation rates Wang C et al., J Vasc Surg 2020 (systematic review, 33 studies)
20% Lifetime lower-extremity amputation incidence among DFU patients McDermott K et al., Diabetes Care 2023
50–70% Five-year mortality rate following a DFU episode — higher than many cancers McDermott K et al., Diabetes Care 2023
Most diabetes-related amputations are preventable. A 2020 systematic review of 33 studies found that multidisciplinary team care consistently reduced major amputation rates, with reductions ranging from 30% to over 80% depending on team composition and care protocols. China's leading DFU centres operate with exactly this model. Wang C et al., J Vasc Surg 2020 (systematic review of 33 studies)

Economic burden of diabetic foot disease

Diabetic foot complications are among the most costly consequences of diabetes, driving hospitalization, emergency visits, and long-term care needs that place enormous strain on healthcare systems worldwide.

$966B Global diabetes health expenditure in 2021 — 11.5% of all adult healthcare spending IDF Diabetes Atlas, 10th ed. (2021)
$273B Direct medical costs of diabetes annually in the United States alone ADA, Diabetes Care 2018 (data for 2017)
5–7× Higher healthcare costs for diabetic patients with foot ulcers vs. those without Raghav A et al., Ther Adv Endocrinol Metab 2018
Foot complications are a leading driver of diabetes hospitalization. DFU patients require more frequent hospital admissions, emergency department visits, outpatient consultations, and home health care than diabetic patients without foot complications. In many healthcare systems, diabetic foot care accounts for a disproportionate share of total diabetes spending. McDermott K et al., Diabetes Care 2023; ADA Economic Costs of Diabetes 2018

DFU etiology & risk factors

Understanding why ulcers develop is key to prevention. The three pathways to ulceration — nerve damage, poor circulation, or both — each demand different clinical strategies.

50% Neuroischemic — mixed nerve damage and vascular disease, the most common DFU type McDermott K et al., Diabetes Care 2023
35% Neuropathic — caused by peripheral nerve damage and loss of protective sensation McDermott K et al., Diabetes Care 2023
15% Ischemic — caused by peripheral arterial disease reducing blood flow to the foot McDermott K et al., Diabetes Care 2023

Key risk factors for DFU development

Peripheral neuropathy Loss of protective sensation — the single most significant predictor of ulceration
Peripheral arterial disease Reduced blood supply impairs wound healing and increases infection risk
Previous DFU or amputation History of ulceration is the strongest predictor of future ulcers
Foot deformity Charcot arthropathy, hammer toes, and bunions create abnormal pressure points
Longer diabetes duration Risk increases with years of diabetes as neuropathy and vascular damage accumulate
Poor glycemic control Elevated HbA1c accelerates nerve damage and impairs immune response

Risk factors per IWGDF Guidelines 2023; Armstrong et al., NEJM 2017; Boulton AJM et al., The Lancet 2005

What specialised care achieves

Outcomes vary dramatically depending on whether a patient receives care at a general facility or a dedicated multidisciplinary DFU centre.

General medical settings

  • 15–25% amputation rate
  • 50–60% healing rate within 20 weeks
  • High recurrence due to limited offloading & follow-up
  • Variable wound-bed preparation protocols

Specialised multidisciplinary centres

  • <5% major amputation rate at leading centres
  • 65–80% healing rate within 20 weeks
  • Structured offloading, debridement & vascular assessment
  • Integrated diabetology, vascular surgery & wound care teams

China's leading DFU centres — treating thousands of cases per year — have systematically adopted multidisciplinary protocols. Volume drives expertise: high-case-count centres report consistently lower amputation rates than low-volume facilities.

Primary sources

  • IDF Diabetes Atlas, 10th Edition (2021). International Diabetes Federation. diabetesatlas.org
  • Armstrong DG, Boulton AJM, Bus SA (2017). Diabetic Foot Ulcers and Their Recurrence. New England Journal of Medicine, 376(24), 2367–2375.
  • Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005). The global burden of diabetic foot disease. The Lancet, 366(9498), 1719–1724.
  • Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y (2017). Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine, 49(2), 106–116.
  • McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW (2023). Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care, 46(1), 209–221.
  • Wang C, Mai L, Yang C, et al. (2020). A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. Journal of Vascular Surgery, 71(4), 1433–1446.e3.
  • Pecoraro RE, Reiber GE, Burgess EM (1990). Pathways to diabetic limb amputation. Diabetes Care, 13(5), 513–521.
  • Wang A et al. (2017). Prevalence and risk factors of diabetic foot ulcers among patients with type 2 diabetes in China. Diabetes Research and Clinical Practice, 130, 166–174.
  • Moulik PK, Mtonga R, Gill GV (2003). Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care, 26(2), 491–494.
  • Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ (2019). Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. BMJ Open Diabetes Research & Care, 7(1), e000645.
  • American Diabetes Association (2018). Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917–928.
  • Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK (2018). Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Therapeutic Advances in Endocrinology and Metabolism, 9(1), 29–31.
  • IWGDF Guidelines (2023). International Working Group on the Diabetic Foot — practical guidelines on prevention and management. iwgdfguidelines.org
  • WHO Global Report on Diabetes (2016). World Health Organization, Geneva. who.int

Statistics reflect the best available published evidence at the time of review. Individual patient outcomes vary. This page does not constitute medical advice.

Questions about DFU treatment options?

Our team connects patients with China's leading specialist centres — free initial consultation, no obligation.

Request a free consultation